Skip to main navigation Skip to search Skip to main content

A BRCA1 promoter variant (rs11655505) and breast cancer risk

  • Paolo Verderio
  • , Sara Pizzamiglio
  • , Melissa C. Southey
  • , Amanda B. Spurdle
  • , John L. Hopper
  • , Xiaoqing Chen
  • , Jonathan Beesley
  • , Rita K. Schmutzler
  • , Christoph Engel
  • , Barbara Burwinkel
  • , Peter Bugert
  • , Filomena Ficarazzi
  • , Siranoush Manoukian
  • , Monica Barile
  • , Barbara Wappenschmidt
  • , Georgia Chenevix-Trench
  • , Paolo Radice
  • , Paolo Peterlongo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: A study of Chinese women recently suggested that the minor allele of rs11655505 in the BRCA1 promoter (c.-2265C→T) increases promoter activity and has a protective effect on breast cancer risk. Methods: We genotyped rs11655505 in 2912 female breast cancer cases and 2783 unaffected female controls from four Caucasian breast cancer studies. Results: No evidence for an association between rs11655505 and breast cancer risk was found. Conclusions: Our study failed to confirm a role of rs11655505 in breast cancer risk. Larger studies are necessary to determine if there is a weak association between this SNP and breast cancer risk.

Original languageEnglish
Pages (from-to)268-270
Number of pages3
JournalJournal of Medical Genetics
Volume47
Issue number4
DOIs
Publication statusPublished - 1 Apr 2010
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this